Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Liposomal glutathione provides the "ready-to-use" molecule protected by a phospholipid bilayer, which may be more efficient for individuals looking for direct support or those with lower synthesis capacity
MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited human safety data Animal toxicology shows wide therapeutic window Injection-site reactions reported anecdotally Known interactions Anticoagulants (theoretical, due to angiogenic activity unstudied) Contraindications Active malignancy (theoretical, due to angiogenic mechanism) Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Placed on FDA Category 2 of the 503A bulks list (September 2023 update), barring compounding pharmacies from preparing it under section 503A
10.1038/s41570-021-00310-4 10.1038/s41570-021-00310-4 [DOI] [PubMed] [Google Scholar] Michel F, Bonnefont-Rousselot D, Mas E, Drai J, Thrond P (2008) Biomarqueurs de la peroxydation lipidique: aspects analytiques [Biomarkers of lipid peroxidation: analytical aspects]
April 2026 Update: All new batches are now validated through an ISO 17025-accredited laboratory , supporting method accuracy, reproducibility, and compliance with recognized analytical standards
For now, MOTS-c is primarily available through research peptide suppliers and is not approved by regulatory agencies like the FDA as a therapeutic agent
S.BennC
US$ 24.11
US$ 24.41
US$ 23.32
